系统性硬化症中的假肿瘤性钙化:系统文献综述与两中心病例系列
本文通过系统文献综述(SLR)和两家转诊中心(Cochin与Padova)的病例系列,探讨系统性硬化症(SSc)相关大块钙化的定义、分布、临床关联与结局。SLR检出30例SSc大块钙化病例;两中心629例SSc中19例存活、7例死亡患者存在假肿瘤性钙化(约3%),多表现为对称性、多部位受累且常伴严重血管表型;药物治疗无明显疗效,部分手术患者见部分改善。
要点
- 假肿瘤性钙化在SSc中约占3%,常对称、多部位,与皮肤亚型无关但多伴严重血管表型。
- 钙化大小2–15.5 cm,常见部位为手/腕52%、肩肘29%、髋20%、脊柱25%。
- 瘘管/溃疡和感染分别见于32%和23%病例;脊柱钙化中40%出现神经压迫。
核心结论
- 假肿瘤性钙化可发生于约3%的SSc患者,常对称、多部位,与皮肤亚型无关但多伴严重血管表型。
- 药物治疗似乎无效,可考虑手术方式。
研究设计与样本
- 系统文献综述(SLR)聚焦SSc相关大块钙化,并回顾Cochin与Padova大学医院所有「假肿瘤性」钙化病例。
- SLR检出30例SSc病例;两中心629例SSc队列中19例存活、7例死亡患者存在假肿瘤性钙化。
主要发现
- 全部56例患者平均年龄59±11.4岁,钙化起病时中位病程7(5-10)年。
- 25/56例(44.6%)为弥漫性皮肤型SSc;抗拓扑异构酶I与抗着丝点抗体检出率相当。
- 假肿瘤性钙化常对称,大小2–15.5 cm;多部位受累:手/腕52%、肩肘29%、髋20%、脊柱25%。
- 瘘管/溃疡和感染分别见于32%和23%病例;脊柱钙化中40%出现神经压迫,1例肢体钙化出现神经压迫。
- 无明确证据显示任何治疗可改善临床和影像学;7例手术患者见部分改善。
关键数值与推荐
- 假肿瘤性钙化在SSc队列中约占3%(19例存活+7例死亡/629例)。
- 钙化起病中位病程7(5-10)年;弥漫性皮肤型占44.6%。
- 部位分布:手/腕52%、肩肘29%、髋20%、脊柱25%;瘘管/溃疡32%、感染23%;脊柱钙化神经压迫40%。
临床怎么用
- 对SSc患者出现对称性、多部位大块钙化(尤其伴严重血管表型)应警惕假肿瘤性钙化。
- 药物治疗效果有限,手术可作为部分患者的考虑选项。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to clarify the definition, distribution, clinical association and outcomes of large calcinosis in patients with systemic sclerosis (SSc). METHODS: We conducted a systematic literature review (SLR) focusing on SSc-related large calcified masses. Upon updating the terminology and definition, all cases of "pseudotumoral" calcinosis seen at the Cochin and Padova University Hospitals were reviewed. RESULTS: The SLR yielded 30 SSc cases, with large calcified masses mainly defined as "tumoral" or "pseudotumoral". Among the 629 SSc cases included in the Cochin and Padova cohorts, 19 (3%) living and 7 deceased patients were affected by pseudotumoral calcinosis; among these, the great majority had a severe vascular phenotype. The mean age in the whole population (56 cases) was 59 ± 11.4 years with a median disease duration at calcinosis onset of 7 (5-10) years. Twenty-five out of 56 patients (44.6%) had the diffuse cutaneous form of SSc. Anti-topisomerase I and anticentromere were found equally. Pseudotumoral calcinosis were commonly symmetrical and the size ranged from 2 to 15.5 cm. Most patients had multiple site involvement: 52% hand/wrist, 29% shoulders and elbows, 20% hips and 25% spinal calcinosis. Fistulization/ulceration and infections were reported in 32% and 23% of cases, respectively; nerve compression was found in 40% of spinal calcinosis and in one patient with limb calcinosis. There was no clear evidence of clinical and radiological improvement with any treatment. A partial improvement was seen in 7 patients that underwent surgery. CONCLUSION: Pseudotumoral calcinosis may occur in about 3% of SSc patients, commonly symmetrical and in multiple sites without differences regarding the cutaneous subtypes but often in those with a severe vascular phenotype. Medical treatment seems ineffective, whereas a surgical approach may be considered.
引用
- Zanatta E, Desportes M, Do HH, et al. Pseudotumoral calcinosis in systemic sclerosis: Data from systematic literature review and case series from two referral centres. Semin Arthritis Rheum. 2020. PMID: 32336495. doi:10.1016/j.semarthrit.2020.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。